4Allford SL,Hunt BJ,Rose P,et al.Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias[J].Br J Haematol,2003,120(4):556-573.
5George JN.How I treat Patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome[J1.Blood,2000,96(4):1223-1229.
2Plaimauer B,Zimmermann K,Volkel D,et al.Cloning,expression,and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13)[J].Blood,2002,100:3626-3632.
4Yomtovian R,Niklinski W,Silver B,et al.Rituximab for chronicrecurring thrombotic thrombocytopenic purpura:a case report and review of the literature[J].Br J Haemat,2004,124(6):787-795.
5Lich t C,Stapenhorst L,Simon T,et al.Two novel ADAM TS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic uremic syndrome(TTP/HU S)[J].Kidney Int,2004,66(3):955-958.
6Dong J-f,Moake J L,Bernardo A,et al.ADAMTS-13 metalloprotease interacts with the endothelial cell-derivedultra-large von Willebrand factor[J].J Biol Chem,2003,278:29633-29639.
7Klaus C,Plaimauer B,Studt J-D,et al.Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura[J].Blood,2004,103:4514-4519.
8Tsai HM.Advances in the pathogenesis,diagnosis,and treatment of TTP[J].J Am Soc Nephrol,2003,14(4):1072-1081.
